To Affinity and Beyond

In the struggle for competitive advantage, businesses need to create purpose-led brands that align with their customers’ own beliefs, finds this report by Accenture.
 
Indeed, 53 percent of customers in the UK want companies to take a stand on issues they care about, such as sustainability, transparency and fair employment practices. Younger consumers, particularly Gen Z, are driving this trend.
 
Key points include:
In the UK, 66 percent of consumers crave greater transparency on how companies source their products, ensure safe working conditions and their stance on issues such as animal testing.
62 percent of customers want companies to stand up for the issues they are passionate about.
42 percent of customers will give the company a second chance if it publicly apologises.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
The Boards' Cyber-Risk Compas...

In this insight, Criticaleye Retreat Partner Palo Alto Networks shares the 10 questions every director should ask to govern, fortify and strategise their organisation’s approach to cyber risk.

Click here to download this insight
The Price of Paralysis

Criticaleye lead Partner AlixPartners paints a stark picture of global volatility, economic fragility, geopolitical shocks and relentless market shifts, in its 2025 'Turnaround and Transformation...

Click here to download this insight
Practical AI for CEOs

AlixPartners’ Practical AI for CEOs playbook cuts through the hype to show how leaders can turn AI ambition into measurable business value. In a market defined by rapid innovation and intensifying competition, the...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 459




IBM Consulting Aldermore Group Workday Rolls-Royce London Stock Exchange Group FTSE Women Leaders Review NatWest Group Salesforce Accenture Worldpay Palo Alto Networks Eightfold AI Drax Group plc British Land Concentrix Google E.ON UK Legal & General AlixPartners Hitachi Solutions NATS GlaxoSmithKline plc Lightsource bp